Journal of Nuclear Cardiology

, Volume 15, Issue 4, pp 604–604 | Cite as

Letter to the editor

  • Goran Koracevic
Article
  • 38 Downloads

Keywords

Digoxin Amiodarone Dilate Cardiomyopathy Carvedilol Nuclear Cardiology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Toyama T, Hoshizaki H, Yoshimura Y, Kasama S, Isobe N, Adachi H, et al. Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: Comparison with carvedilol therapy alone. J Nucl Cardiol 2008;15:57–64.PubMedCrossRefGoogle Scholar
  2. 2.
    Nägele H, Bohlmann M, Eck U, Petersen B, Rödiger W. Combination therapy with carvedilol and amiodarone in patients with severe heart failure. Eur J Heart Fail 2000;2:71–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Thomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray JJ, et al. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. Am Heart J 2008;155:87–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Koraćević GP, Burazor M, Tomašević M, Perišić Z, Apostolović S, Mihajlović A. An account of a seven year experience with carvedilol and amiodarone in severe congestive heart failure patients with sinus tachycardia. Facta Univ (Med Biol) 2003;10:69–75.Google Scholar

Copyright information

© American Society of Nuclear Cardiology 2008

Authors and Affiliations

  • Goran Koracevic
    • 1
  1. 1.Department for Cardiovascular DiseasesUniversity Clinical CentreNišSerbia

Personalised recommendations